These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11360198)

  • 1. Mutant K-ras enhances apoptosis in embryonic stem cells in combination with DNA damage and is associated with increased levels of p19(ARF).
    Brooks DG; James RM; Patek CE; Williamson J; Arends MJ
    Oncogene; 2001 Apr; 20(17):2144-52. PubMed ID: 11360198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells.
    Corbet SW; Clarke AR; Gledhill S; Wyllie AH
    Oncogene; 1999 Feb; 18(8):1537-44. PubMed ID: 10102623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional upregulation of p19INK4d upon diverse genotoxic stress is critical for optimal DNA damage response.
    Ceruti JM; Scassa ME; Marazita MC; Carcagno AC; Sirkin PF; Cánepa ET
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1344-53. PubMed ID: 19130897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis.
    Downing S; Bumak C; Nixdorf S; Ow K; Russell P; Jackson P
    Mol Carcinog; 2003 Nov; 38(3):130-40. PubMed ID: 14587098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo].
    Zhang ZP; Jiang GC; Yang F; Zhou ZL; Wang J
    Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(18):1267-70. PubMed ID: 18067742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of p53 in death of IL-3-dependent cells in response to cytotoxic drugs.
    Palacios C; Gutierrez del Arroyo A; Silva A; Collins MK
    Oncogene; 2000 Jul; 19(31):3556-9. PubMed ID: 10918614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice.
    Plowman SJ; Arends MJ; Brownstein DG; Luo F; Devenney PS; Rose L; Ritchie AM; Berry RL; Harrison DJ; Hooper ML; Patek CE
    Exp Cell Res; 2006 Jan; 312(1):16-26. PubMed ID: 16271715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
    Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
    Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
    de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomas.
    James RM; Arends MJ; Plowman SJ; Brooks DG; Miles CG; West JD; Patek CE
    Mol Cancer Res; 2003 Sep; 1(11):820-5. PubMed ID: 14517344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.
    Beuvink I; Boulay A; Fumagalli S; Zilbermann F; Ruetz S; O'Reilly T; Natt F; Hall J; Lane HA; Thomas G
    Cell; 2005 Mar; 120(6):747-59. PubMed ID: 15797377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cellular response to cisplatin-induced DNA damage and DNA repair in cells overexpressing p185(erbB-2) is dependent on the ras signaling pathway.
    Yen L; Nie ZR; You XL; Richard S; Langton-Webster BC; Alaoui-Jamali MA
    Oncogene; 1997 Apr; 14(15):1827-35. PubMed ID: 9150389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of functional pRb results in attenuated recovery of mRNA synthesis and increased apoptosis following UV radiation in human breast cancer cells.
    Billecke CA; Ljungman ME; McKay BC; Rehemtulla A; Taneja N; Ethier SP
    Oncogene; 2002 Jul; 21(29):4481-9. PubMed ID: 12085226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of apoptosis after thymineless stress is conferred by oncogenic K-Ras in colon carcinoma cells.
    Houghton JA; Ebanks R; Harwood FG; Tillman DM
    Clin Cancer Res; 1998 Nov; 4(11):2841-8. PubMed ID: 9829751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant K-rasV12 increases COX-2, peroxides and DNA damage in lung cells.
    Maciag A; Sithanandam G; Anderson LM
    Carcinogenesis; 2004 Nov; 25(11):2231-7. PubMed ID: 15284181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tumor suppressor p53 facilitates DNA repair but not UV-induced G2/M arrest or apoptosis in Chinese hamster ovary CHO-K1 cells.
    Chang YC; Liao CB; Hsieh PY; Liou ML; Liu YC
    J Cell Biochem; 2008 Feb; 103(2):528-37. PubMed ID: 17549699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6.
    Billadeau D; Liu P; Jelinek D; Shah N; LeBien TW; Van Ness B
    Cancer Res; 1997 Jun; 57(11):2268-75. PubMed ID: 9187131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.